Average Co-Inventor Count = 3.76
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Anaptysbio, Inc. (10 from 21 patents)
2. Lassen Therapeutics, Inc. (2 from 2 patents)
3. Pharmacopeia Drug Discovery, Inc. (1 from 52 patents)
4. Pharmacopeia Drug Disclovery, Inc. (1 from 1 patent)
5. Lassen Therapeutics 1, Inc. (1 from 1 patent)
15 patents:
1. 12365737 - Anti-IL-18BP antibodies
2. 12365738 - Method of treating an interleukin-11-associated or -mediated fibrotic disease or condition by administering an anti-interleukin-11 receptor subunit alpha (IL-11RA) antibody
3. 12129303 - Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies
4. 11999783 - Method of treating autoimmune disease with antibodies against IL-33
5. 10836820 - Method of treating inflammatory disorder with antibodies directed against interleukin-33 (IL-33)
6. 10059764 - Antibodies directed against interleukin-33 (IL-33) and methods of making and using
7. 9951126 - Antibodies directed against nerve growth factor (NGF)
8. 9637556 - Methods of generating libraries and uses thereof
9. 9328166 - Antibodies directed against IL-17
10. 9260533 - Methods of generating libraries and uses thereof
11. 8926978 - Antibodies directed against nerve growth factor (NGF)
12. 8685897 - Methods of generating libraries and uses thereof
13. 8603950 - Methods of generating libraries and uses thereof
14. 7084154 - 2-(aminomethyl) arylamide analgesics
15. 7041463 - Orthologues of human receptors and methods of use